Treatment of Granulomatosis with Polyangiitis and Microscopic Polyangiitis: Should Type of ANCA Guide the Treatment?

Clin J Am Soc Nephrol. 2020 Oct 7;15(10):1519-1521. doi: 10.2215/CJN.15861219. Epub 2020 May 29.
No abstract available

Keywords: ANCA; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies; Antineutrophil Cytoplasmic; vasculitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Antineutrophil Cytoplasmic*
  • Azathioprine / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Granulomatosis with Polyangiitis / complications
  • Granulomatosis with Polyangiitis / drug therapy*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Diseases / etiology
  • Kidney Diseases / physiopathology
  • Maintenance Chemotherapy
  • Microscopic Polyangiitis / complications
  • Microscopic Polyangiitis / drug therapy*
  • Myeloblastin / immunology*
  • Peroxidase / immunology*
  • Recurrence
  • Rituximab / therapeutic use

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Immunosuppressive Agents
  • Rituximab
  • Cyclophosphamide
  • MPO protein, human
  • Peroxidase
  • Myeloblastin
  • Azathioprine